Q37325003 | ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2). |
Q27024427 | An update on microRNAs as colorectal cancer biomarkers: where are we and what's next? |
Q38928155 | Blocking the maturation of OncomiRNAs using pri-miRNA-17∼92 aptamer in retinoblastoma |
Q37438786 | Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients. |
Q36857592 | Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer |
Q33720978 | Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs |
Q35123713 | DNA damage response and DNA repair - dog as a model? |
Q43554998 | Diagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancer |
Q36291392 | Differential Sensitivity of Target Genes to Translational Repression by miR-17~92. |
Q48088320 | Expression Profiling of MicroRNAs in the Inner Ear of Elderly People by Real-Time PCR Quantification |
Q89909098 | Function and mechanisms of microRNA-20a in colorectal cancer |
Q90298858 | Identification of miR-18a-5p as an oncogene and prognostic biomarker in RCC |
Q38430180 | Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles |
Q36378546 | Investigation of microRNA expression and DNA repair gene transcripts in human oocytes and blastocysts |
Q34435277 | Linking ATM Promoter Methylation to Cell Cycle Protein Expression in Brain Tumor Patients: Cellular Molecular Triangle Correlation in ATM Territory |
Q38937055 | Micro RNAs: an arguable appraisal in medicine. |
Q38262497 | MicroRNA dysregulation as a prognostic biomarker in colorectal cancer |
Q37034049 | MicroRNA expression and its association with DNA repair in preimplantation embryos |
Q39037653 | MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance |
Q38331867 | MicroRNA-mRNA interactions in colorectal cancer and their role in tumor progression |
Q58923813 | MicroRNAs in Cancer Drug Resistance and Drug Sensitivity |
Q37708024 | MicroRNAs in colorectal cancer as markers and targets: Recent advances |
Q21284509 | MicroRNAs in the DNA Damage/Repair Network and Cancer |
Q37731180 | MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications |
Q35673637 | MicroRNAs: short non-coding players in cancer chemoresistance. |
Q27028132 | Microbiota impact on the epigenetic regulation of colorectal cancer |
Q39202038 | NLRP3 inflammasome: Its regulation and involvement in atherosclerosis |
Q37009459 | Non-coding RNAs in DNA damage and repair |
Q26773316 | Oncogenic MicroRNAs: Key Players in Malignant Transformation |
Q55007045 | PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation. |
Q39070721 | Potential roles of microRNAs and ROS in colorectal cancer: diagnostic biomarkers and therapeutic targets |
Q38555225 | Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon |
Q61811544 | Prognostic value of miR17-92 family in patients with digestive system cancers: a systematic review and meta-analysis |
Q55307845 | Prognostic value of microRNAs in colorectal cancer: a meta-analysis. |
Q34989673 | Radioactive ¹²⁵I seed inhibits the cell growth, migration, and invasion of nasopharyngeal carcinoma by triggering DNA damage and inactivating VEGF-A/ERK signaling |
Q64963313 | Radiosensitizing effects of miR-18a-5p on lung cancer stem-like cells via downregulating both ATM and HIF-1α. |
Q26797350 | Regulatory Roles of Non-Coding RNAs in Colorectal Cancer |
Q38264776 | Role of miRNA in head and neck squamous cell carcinoma |
Q41239908 | Targeting MicroRNAs in Prostate Cancer Radiotherapy |
Q92232785 | The dual functional role of MicroRNA-18a (miR-18a) in cancer development |
Q36963164 | Use of microRNAs in directing therapy and evaluating treatment response in colorectal cancer |
Q57165706 | miR-18a-5p promotes cell invasion and migration of osteosarcoma by directly targeting IRF2 |
Q47818301 | miR-300 regulates cellular radiosensitivity through targeting p53 and apaf1 in human lung cancer cells. |
Q38160950 | microRNAs in cancer cell response to ionizing radiation. |